CVS

CVS Health CorporationNYSEHealthcare

$73.49+1.38%OpenMarket Cap: $93.49B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-31	Piper Sandler	—	Overweight	—
2026-03-12	Bernstein	—	Outperform	—
2026-01-28	Argus Research	—	Buy	—
2026-01-27	B of A Securities	—	Buy	—
2026-01-06	Bernstein	—	Market Perform	—
2025-12-17	JP Morgan	—	Overweight	—
2025-12-10	Morgan Stanley	—	Overweight	—
2025-12-10	Barclays	—	Overweight	—
2025-12-10	Piper Sandler	—	Overweight	—
2025-12-10	Baird	—	Outperform	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$8.16	$424.63B	17
Sun Dec 31	$9.41	$447.92B	10
Mon Dec 31	$10.47	$475.37B	4
Tue Dec 31	$11.47	$495.60B	4